Our analysis therefore shows that the proportions of endometrial CD56+ NK cells, CD8+ T cells, Foxp3+ Treg cells, and T-bet+ Th1 cells were significantly decreased in persistent CE patients after PRP treatment compared with those before PRP treatment. The gene discussed is NCAM1; the disease is cholesteryl ester measurement.